Gender influence on the immediate and medium-term progression after primary percutaneous coronary intervention and analysis of independent risk factors for death or events

Arquivos Brasileiros de Cardiologia

Volumn 86, Issue 3, 2006, Pages 211-218

  Sandoval Peixoto, Rodrigo Trajano ^a   Sandoval Peixoto, Edison Carvalho ^a,b   Sena, Marcello Augustus ^a   Tedeschi, Angelo Leone ^a   Borges, Ivana Picone ^a   Freitas Rachid, Maurício Bastos ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b NONE   (Brazil)

Author keywords

Acute myocardial infarction; Gender; Primary coronary angioplasty; Risk factors

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; DEATH; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RISK FACTOR; SEX DIFFERENCE; STABLE ANGINA PECTORIS; AGE; ANGINA PECTORIS; EPIDEMIOLOGY; MIDDLE AGED; PATHOLOGY; SEX RATIO; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SEX DISTRIBUTION; SEX FACTORS; TREATMENT OUTCOME;

EID: 33645654341     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Foody JM. Coronary artery disease and women. In: Marso SP, Griffin BP, Topol EJ. Manual of Cardiovascular Medicine. Philadelphia: Lippincott Williams & Wilkins, 2000: 482.
2. Lerner DJ, Kannel WB. Patterns of heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383-90.
3. Sullivan AK, Holdright DR, Wright CA et al. Chest pain in women: Clinical, investigative, and prognostic features. Br Med J 1994; 308: 883-9.
4. Barret-Connor E. Sex differences in coronary heart disease: why are women so superior? The 1995 Ancel Keys Lecture. Circulation 1997; 95: 252-64.
5. Chandra NC, Ziegelstein RC, Rogers WJ et al. Observations of treatment of women in the United States with myocardial infarction: A report from the National Registry of Myocardial Infarction-I. Arch Intern Med 1998; 158: 981-8.
6. Collins LJ, Douglas PS. Acute coronary syndromes. In Charney P. Coronary Artery Disease in Women. Philadelphia: American College of Physicians, 1999, 407.
7. Weaver WD, Simes RJ, Betriu A et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997; 278: 2093-8.
8. Stone GW, Brodie BR, Griffin JJ et al. Prospective multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary angioplasty in myocardial infarction stent pilot trial investigators. J Am Col Cardiol 1998; 31: 23-30.
9. Grines CL, Cox DA, Stone GW et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent primary angioplasty in myocardial infarction study group. N Eng J Med 1999; 341: 1949-56.
10. Montalescot G, Barragan P, Wittenberg O et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895-903.
11. Tcheng JE, Kandzari DE, Grimes CL et al. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abiciximab and Device Investigation to Lower Late Angioplasty Complication (CADILLAC) trial. Circulation 2003; 108: 1316-23.
12. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The global use of strategies to open ocluded coronary arteries in acute coronary syndromes (GUSTO IIb) angioplasty substudy investigators. N Eng J Med 1997; 336: 1621-8.
13. Brodie BR, Stuckey TD, Wall TC et al. Importance of time to reperfusion for hospital and long-term survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998; 32: 1312-9.
14. Abbo KM, Dooris M, Glasier S et al. Features and outcome of "no-reflow" after percutaneous coronary intervention. Am J Cardiol 1995; 75: 778-82.
15. Marzilli M, Gliozheni E, Marraccini P, Erdili S. Primary coronary angioplasty in acute myocardial infarction: clinical correlates of the "no ref ow"phenomenon. Int J Cardiol 1998; 65(Suppl.1): S23-8.
16. Judkins MP. Selective coronary arteriography. A percutaneous transfemoral technic. Radiology 1967; 89: 815-24.
17. rd, Douglas Jr JS, Cox WR. Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty. Am J Cardiol 1989; 63: 30-4.
18. Peixoto RTS. Influência do sexo na evolução intra-hospitalar e a médio prazo nos pacientes tratados com intervenção coronária percutânea primária. Niterói, 2003. Dissertação (Mestrado em Cardiologia) - Universidade Federal Fluminense.
19. Dittrich H, Gilpin E, Nicod P, Cali G, Henning H, Ross Jr J. Acute MI in women: influence of gender on mortality and prognostic variables. Am J Cardiol 1988; 62: 1-7.
20. Malacrida R, Genoni M, Maggioni AP et al. A comparison of the early outcome of acute MI in women and men. The third international study of infarct survival collaborative group. N Engl J Med 1998; 338: 8-14.
21. Azar RR, Waters DD, McKay RG et al. Short and medium-term outcome differences in women and men after primary percutaneous transluminal mechanical revascularization for acute myocardial infarction. Am J Cardiol 2000; 85: 675-79.
22. Antoniucci D, Valenti R, Moschi G et al. Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol 2001; 87: 289-93.
23. Stone GW, Grines CL, Browne KF et al. Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute MI. Am J Cardiol 1995; 75: 987-92.
24. Vakili BA, Kaplan RC, Brawn DL. Sex-based differences in early mortality of patients undergoing primary angioplasty for first acute myocardial infarction. Circulation 2001; 104: 3034-8.
25. Angela BG, Gibson CM, Chin R. Predictors of door-to-ballon delay in primary angioplasty. Am J Cardiol 2002; 89: 1156-61.
26. Vacek JL, Rosamond TL, Kramer PH et al. Sex-related differences in patients undergoing direct angioplasty for acute myocardial infarction. Am Heart J 1993; 126: 521-5.
27. Brener SJ, Barr LA, Benchenal JE. Randomized, placebo-controled trial of platelet glycoprotein IIb/IIIa blockage with primary angioplasty for acute MI. ReoPro and primary PTCA organization and randomized trial (RAPPORT) investigators. Circulation 1998; 98: 734-41.
28. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967; 20: 457-64.
29. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. N Engl J Med 1999; 341: 217-25.
30. Mehilli J, Kastrati A, Dirschinger J et al. Sex-based analysis of outcome in patients with myocardial infarction treated predominantly with percutaneous coronary intervention. JAMA 2002; 287: 210-5.
31. Cowley MJ, Meullin SM, Kelsey SF et al. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA registry. Circulation 1985; 71: 90-7.
32. Hirshfeld JW, Schuartz JS, Jugo R et al. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART investigators. J Am Coll Cardiol 1991; 18: 647-56.
33. Mintz GS, Popma JJ, Pichard AD et al. Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization. J Am Coll Cardiol 1996; 27: 1678-87.